Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06409507
Status:
COMPLETED
Last Update Posted:
2024-05-10
First Post:
2024-05-07
Brief Title:
Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation
Sponsor:
First Peoples Hospital of Hangzhou
Organization:
First Peoples Hospital of Hangzhou
Study Overview
Official Title:
The Impact of FKBP12 on the Prognosis and Sirolimus Administration in Liver Transplantation Recipients With Hepatocellular Carcinoma A Single-center Retrospective Cohort Study
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study evaluated the protein expression levels of FK506-binding protein 12 FKBP12 in hepatocellular carcinoma HCC and paracancerous tissues using immunohistochemistry IHC This study aimed to determine the role of FKBP12 in the outcome of liver transplantation recipients with HCC especially those exceeding the Milan criteria In addition we explored how sirolimus administration affected LT recipientsprognosis depending on different FKBP12 expression aiming to provide some advice for clinical sirolimus application after LT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None